Skip to content

The intent of this document is to provide adaptable guidelines to support the development and adoption of national guidelines that align with World Health Organization (WHO) pre-exposure prophylaxis (PrEP) recommendations and guidance, including those for tenofovir disoproxil fumarate (TDF)-based daily and event-driven oral PrEP, the monthly dapivirine vaginal ring (“PrEP ring” or “the ring”), and injectable cabotegravir (CAB PrEP). The document includes prompts for national-level consideration during the guideline adaptation process.

This is the French version of the guidelines. For the English version, please click here. For the Spanish version, please click here.

Featured Resources